return to news
  1. Sai Parenteral's IPO allotment: How to check status online on NSE, BSE, Bigshare Services; listing date, time here

Market News

Sai Parenteral's IPO allotment: How to check status online on NSE, BSE, Bigshare Services; listing date, time here

Kamal Joshi

3 min read | Updated on March 30, 2026, 09:16 IST

Twitter Page
Linkedin Page
Whatsapp Page

SUMMARY

Sai Parenteral's IPO allotment: The ₹408.79 crore issue, with a price band of ₹372 to ₹392 per equity share, was a fresh issuance of shares worth ₹285 crore and an offer-for-sale (OFS) component of ₹123.79 crore.

IPo allotment status date time | Sai Parenteral's is a diversified pharmaceutical formulations firm with capabilities in research, development and manufacturing. | Image: saiparenteral.com

Sai Parenteral's is a diversified pharmaceutical formulations firm with capabilities in research, development and manufacturing. | Image: saiparenteral.com

Sai Parenteral's IPO allotment: The basis of allotment of Sai Parenteral's IPO is expected to be finalised on Monday, March 30. The bid finalisation details will go live on the websites of the NSE, the BSE and the registrar, Bigshare Services.

Open FREE Demat Account within minutes!
Join now

The initial public offering of the diversified pharmaceutical formulation company was subscribed 1.05 times. It mobilised bids for 78,80,972 shares compared to 75,22,486 shares on offer, according to the NSE data.

The portion for non-institutional investors (NIIs) was subscribed 2.36 times, while the part for qualified institutional buyers (QIBs) was booked 1.71 times. The retail investors' quota attracted 12% bidding.

The ₹408.79 crore IPO, with a price band of ₹372 to ₹392 per equity share, was a fresh issue worth ₹285 crore and an offer-for-sale (OFS) component of ₹123.79 crore.

Under the OFS, Devendra Chawla, Vikasa India EIF I Fund, Tilokchand Punamchand Ostwal, Bhanwar Lal Chandak, Sreelekha Ganta, Ashish Maheshwari, Vijay Gondi, Padma Guntupalli, Nilesh Pravinchandra Doshi and Bhautik Mukund Shah will sell their stake.

The money raised will be used to support the company's expansion, establish a new R&D centre, debt repayment, working capital needs, invest in a wholly-owned subsidiary and general corporate purposes.

Sai Parenteral's, a diversified pharmaceutical formulations company, has capabilities in research, development and manufacturing. It is engaged in the business of branded generic formulations and CDMO (contract development and manufacturing organisation) products and services for the domestic and international markets.

Sai Parenteral's IPO allotment date and time

Sai Parenteral's IPO allotment status is likely to be finalised on Monday, March 30, by late evening.

CMPDI IPO Listing Live Updates: Track all key developments here

How to check Sai Parenteral's IPO allotment status online on NSE

Steps to check Sai Parenteral's IPO allotment status online on BSE

  • Head to BSE's IPO application status website: https://bseindia.com/investors/appli_check.aspx
  • Keep issue type as 'Equity'
  • From the IPO names, select 'Sai Parenteral's Ltd'
  • Mention your PAN or IPO application number
  • Click on the 'Search' button

Sai Parenteral's IPO allotment status online on Bigshare Services; full steps here

  • Go to the IPO status page of Bigshare Services website: www.bigshareonline.com/ipo_Allotment.html
  • From the three servers shown on your screen, choose any one
  • Choose 'Sai Parenteral's Ltd'
  • Add any one: application number, PAN or beneficiary ID
  • Hit the ‘Search’ button

Sai Parenteral's IPO listing date and time

Shares of Sai Parenteral's will start trading on the NSE and the BSE on Thursday, April 2, at 10 am.

To learn more about IPOs, their listings, schedules, and upcoming IPOs, visit our page.

To add Upstox News as your preferred source on Google, click here.

About The Author

Kamal Joshi
Kamal Joshi is a business journalist who covers industries, markets, and IPOs. He is passionate about breaking news and enjoys playing tennis, especially flexing his backhand. He was previously associated with Republic TV and LatestLY.

Next Story